U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06386419) titled 'A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia' on April 23.

Brief Summary: This study is to generate post-marketing safety and effectiveness data of inclisiran sodium in Indian patients as per approved indication i.e., primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia that more closely resembles the real-world population intended to be treated with inclisiran sodium.

Study Type: Interventional

Condition: * Primary Hypercholesterolemia

* Mixed Dyslipidemia

Intervention: Drug: incli...